2024 Annual Meeting | H214 - Digital Health Solutions: The Promise and Peril of Medical Apps (Innovation Hub)

Date Wednesday 04/17/24

Time 12:30 PM - 01:00 PM MDT Add To Calendar

Location Colorado Convention Center | Exhibit Hall B-E

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs (Innovation)

Director(s) Darin T. Okuda, MD, FAAN, Kevin Shan

Topic(s) General Neurology

Learning Objectives A variety of short presentations that will cover digital health solutions with a principal focus on apps, the evolution and demise of prescription digital therapeutics, most common resources utilized by people affected by disease as well as resources used by healthcare providers, etc.

CME Available No CME available

Program Tracks Advanced Practice Provider

Program Materials Program Evaluations

Event Timeline
12:30 PM - 01:00 PM MDT	Speaker	Digital Health Solutions: The Promise and Peril of Medical Apps Darin T. Okuda, MD, FAAN, Kevin Shan

Faculty Disclosures
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RVL Pharmaceuticals, Inc.. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas BioPharma. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from EMD Serono. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Kevin Shan	No disclosure on file